These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 9138110)

  • 1. Expression of CD44 isoforms and beta 1,6-branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential.
    Seelentag WK; Böni R; Günthert U; Futo E; Burg G; Heitz PU; Roth J
    J Cutan Pathol; 1997 Apr; 24(4):206-11. PubMed ID: 9138110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 and variants in melanocytic skin neoplasms.
    Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
    J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 and melanocytic tumors: a possible role for standard CD44 in the epidermotropic spread of melanoma.
    Fernández-Figueras MT; Ariza A; Calatrava A; Puig L; Fernández-Vasalo A; Ferrándiz C
    J Cutan Pathol; 1996 Apr; 23(2):133-9. PubMed ID: 8721447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44s and CD44 splice variants in human melanoma.
    Ranuncolo SM; Ladeda V; Gorostidy S; Morandi A; Varela M; Lastiri J; Loria D; Del Aguila R; Joffé EB; Pallotta G; Puricelli L
    Oncol Rep; 2002; 9(1):51-6. PubMed ID: 11748454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD44v3 splice variant is associated with the visceral metastatic phenotype of human melanoma.
    Döme B; Somlai B; Ladányi A; Fazekas K; Zöller M; Tímár J
    Virchows Arch; 2001 Nov; 439(5):628-35. PubMed ID: 11764382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 loss in gastric stromal tumors as a prognostic marker.
    Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
    Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 expression in benign and malignant nevomelanocytic lesions.
    Leigh CJ; Palechek PL; Knutson JR; McCarthy JB; Cohen MB; Argenyi ZB
    Hum Pathol; 1996 Dec; 27(12):1288-94. PubMed ID: 8958300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of CD44 variant isoforms in human skin: differential expression in components of benign and malignant epithelia.
    Hale LP; Patel DD; Clark RE; Haynes BF
    J Cutan Pathol; 1995 Dec; 22(6):536-45. PubMed ID: 8835172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 splice variants in human primary brain tumors.
    Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST
    J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 expression in melanocytic lesions: a marker of malignant progression?
    Harwood CA; Green MA; Cook MG
    Br J Dermatol; 1996 Dec; 135(6):876-82. PubMed ID: 8977706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast.
    Berner HS; Nesland JM
    Breast Cancer Res Treat; 2001 Jan; 65(1):23-9. PubMed ID: 11245336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential.
    Manten-Horst E; Danen EH; Smit L; Snoek M; Le Poole IC; Van Muijen GN; Pals ST; Ruiter DJ
    Int J Cancer; 1995 Jun; 64(3):182-8. PubMed ID: 7542641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 standard and variant isoform expression in normal human skin appendages and epidermis.
    Seelentag WK; Günthert U; Saremaslani P; Futo E; Pfaltz M; Heitz PU; Roth J
    Histochem Cell Biol; 1996 Sep; 106(3):283-9. PubMed ID: 8897069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of CD44 isoforms in normal human liver and also in regenerative and neoplastic liver changes].
    Seelentag WK; Flury R; Schmid M; Komminoth P; Saremaslani P; Günthert U; Heitz PU; Roth J
    Verh Dtsch Ges Pathol; 1995; 79():144-7. PubMed ID: 8600679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma.
    Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH
    Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 and the pattern of CD44 alternative splicing in uveal melanoma.
    Danen EH; ten Berge PJ; van Muijen GN; Jager MJ; Ruiter DJ
    Melanoma Res; 1996 Feb; 6(1):31-5. PubMed ID: 8640067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gains and losses of CD44 expression during breast carcinogenesis and tumour progression.
    Bànkfalvi A; Terpe HJ; Breukelmann D; Bier B; Rempe D; Pschadka G; Krech R; Böcker W
    Histopathology; 1998 Aug; 33(2):107-16. PubMed ID: 9762542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased survival in patients with CD44-negative typical bronchial carcinoid tumors.
    Granberg D; Wilander E; Oberg K; Skogseid B
    Int J Cancer; 1999 Oct; 84(5):484-88. PubMed ID: 10502723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44 variants in osteosarcoma.
    Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage?
    Regauer S; Ott A; Berghold A; Beham A
    J Pathol; 1999 Jan; 187(2):184-90. PubMed ID: 10365093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.